DNA damage and mutation: Contributors to the age-related alterations in T cell-mediated immune responses?

Mechanisms of Ageing and Development

Volumn 102, Issue 2-3, 1998, Pages 165-176

  Barnett, Yvonne Annette ^a   Barnett, Christopher Robert ^a  

^a UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

Ageing; Apoptosis; DNA damage; Immune response; Mutation; T lymphocytes

Indexed keywords

AGING; APOPTOSIS; CELL CYCLE; CONFERENCE PAPER; DNA DAMAGE; DNA REPAIR; GENE MUTATION; GENETIC DAMAGE; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MEMORY CELL; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0032525010     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0047-6374(98)00018-9     Document Type: Conference Paper

References (49)

1. Allsopp, R.C., Vaziri, H., Patterson, C. et al., 1992. Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl. Acad. Sci. USA 89, 10114-10118.
2. Ames, B.N., Shigenaga, M.K., Hagen, T.M., 1993. Oxidants, antioxidants and the degenerative diseases of aging. Proc. Natl. Acad. Sci. USA 90, 7915-7922.
3. Barnett, Y.A., King, C.M., 1995. An investigation of in vivo antioxidant status, DNA repair capacity and mutation as a function of age in humans. Mutation Res. 338, 115-128.
4. Berger, N.A., 1985. Symposium: cellular response to DNA damage - the role of poly(ADP-ribose). Poly(ADP-ribose) in the cellular response to DNA damage. Radiat. Res. 101, 4-15.
5. Breimer, L.H., 1990. Molecular mechanisms of oxygen radical carcinogenesis and mutagenesis: the role of DNA base damage. Mol. Carcinogenesis 3, 188-197.
6. Bunker, V.W., 1992. Free radicals, antioxidants and ageing. Med. Lab. Sci. 49, 299-312.
7. Buttke, T.M., Sandstrom, P.A., 1994. Oxidative stress as a mediator of apoptosis. Immunol. Today 15, 7-10.
8. Cakman, I., Rohwer, J., Schutz, R.M., Kirchner, H., Rink, L., 1996. Dysregulation between TH1 and TH2 T cell subpopulations in the elderly. Mech. Ageing Dev. 87, 197-209.
9. Cole, J., Green, M.H.L., James, S.E., Henderson, L., Cole, H., 1988. A further assessment of factors influencing measurements of thioguanine-resistant mutant frequency in circulating T-lymphocytes. Mutation Res. 204, 4983-5007.
10. Cole, J., Waugh, A.P.W., Beare, D.M. et al., 1991. HPRT mutant frequencies in circulating lymphocytes: population studies using normal donors, exposed groups and cancer prone syndromes. In: Gledhill, B.L., Mauro, F. (Eds.), New Horizons in Biological Dosimetry. Wiley-Liss, New York, pp. 319-328.
11. Dempsey, J.L., Morley, A.A., Seshadri, R.S. et al., 1983. Detection of the carrier state for an X-linked disorder, the Lesch-Nyhan syndrome, by the use of lymphocyte cloning. Hum. Genet. 64, 288-290.
12. Effros, R.B., Boucher, N., Porter, V. et al., 1994. Decline in CD28(+) T cells in centenarians and in long-term T cell cultures: a possible cause for both in vivo and in vitro immunosenescence. Exp. Gerontol. 29, 601-609.
13. Effros, R.B., 1996. Insights on immunological aging derived from the T lymphocyte cellular senescence model. Exp. Gerontol. 31, 21-27.
14. Fenech, M., Morley, A.A., 1985. The effect of donor age on spontaneous and induced micronuclei. Mutation Res. 148, 99-105.
15. Franceschi, C., Monti, D., Cossarizza, A. et al., 1991. Aging, longevity and cancer: studies in Down's syndrome and centenarians. Annals. NY Acad. Sci. 621, 428-440.
16. Franceschi, C., Monti, D., Scarfi, M.R. et al., 1992. Genomic stability and aging: studies in centenarians (successful aging) and in patients with Down's syndrome (accelerated aging). Annals. NY Acad. Sci. 663, 4-16.
17. Franceschi, C., Monti, D., Sansoni, P., Cossarizza, A., 1995. The immunology of exceptional individuals: the lesson of centenarians. Immunol. Today 12, 12-16.
18. Gmunder, H., Eck, H.-P., Benninghoff, B., Roth, S., Droge, W., 1990. Interleukin-2 messenger RNA expression lymphokine production and DNA synthesis in glutathione-depleted T cells. Cell. Immunol. 130, 520-528.
19. Gregory, S.H., Wing, E.J., Hoffman, R.A., Simmons, R.L., 1993. Reactive nitrogen intermediates suppress the primary immunologic response to Listeria. J. Immunol. 150, 2901-2909.
20. Hannet, I., Erkelleryuksel, F., Lydyard, P., Deneys, V., Debruyere, M., 1992. Developmental and maturational changes in human blood lymphocyte subpopulations. Immunol. Today 13, 215-218.
21. Harley, C.B., Futcher, A.B., Greider, C.W., 1990. Telomeres shorten during ageing of human fibroblasts. Nature 345, 458-460.
22. Hartwell, L.H., Kastan, M.B., 1994. Cell cycle control and cancer. Science 266, 1821-1828.
23. Hayatsu, H. (Ed.), 1991. Mutagens in Food: Detection and Prevention. CRC Press, Boca Raton, Florida.
24. Hayflick, L., Moorehead, P.S., 1961. The serial cultivation of human diploid cell strains. Exp. Cell Res. 25, 585-621.
25. Hirose, K., Longo, D.L., Oppenheim, J.J., Matsushima, K., 1993. Overexpression of mitochondrial manganese superoxide dismutase promotes the survival of tumor cells exposed to Interleukin-1 Tumor necrosis factor selected anticancer drugs and ionising radiation. FASEB J. 7, 361-368.
26. Inamizu, T., Kinohara, N., Chang, M.-P., Makinodan, T., 1986. Frequency of 6-thioguanine-resistant T cells is inversely related to the declining T-cell activities in aging mice. Proc. Natl. Acad. Sci. USA 83, 2488-2491.
27. Kaufmann, W.K., Paules, R.S., 1996. DNA damage and cell cycle checkpoints. FASEB J. 10, 238-247.
28. King, C.M., Gillespie, E.S., McKenna, P.G., Barnett, Y.A., 1994. An investigation of mutation as a function of age in humans. Mutation Res. 316, 79-90.
29. King, C.M., Bristow-Craig, H.E., Gillespie, E.S., Barnett, Y.A., 1997. In vivo antioxidant status, DNA damage, mutation and DNA repair capacity in cultured lymphocytes from healthy 75-80 year-old humans. Mutation Res. 377, 137-147.
30. Lindahl, T., 1993. Instability and decay of the primary structure of DNA. Nature 362, 709-715.
31. Lipsky, P.E., 1985. Immunosuppression by D-penicillamine in vitro: inhibition of human T lymphocyte proliferation by copper-dependent or ceruloplasmin-dependent generation of hydrogen peroxide and protection by monocytes. J. Clin. Invest. 73, 53-65.
32. McClean, A.R., Michie, C.A., 1995. In vitro estimates of division and death rates of human T lymphocytes. Proc. Natl. Acad. Sci. USA 92, 3707-3711.
33. Metzger, Z., Hoffeld, J.T., Oppenheim, J.J., 1980. Macrophage-mediated suppression: I Evidence for participation of both hydrogen peroxide and prostaglandins in suppression of murine lymphocyte proliferation. J. Immunol. 124, 983-988.
34. Michie, C.A., McClean, A., Alcock, C., Beverley, P.C.L., 1992. Lifespan of human lymphocyte subsets defined by CD45 isoforms. Nature 360, 264-265.
35. Morley, A.A., Cox, S., Holliday, R., 1982. Human lymphocytes resistant to 6-thioguanine increase with age. Mech. Age Dev. 19, 21-26.
36. Mullaart, E., Boerrigter, M.E.T.I., Brouwer, A., Vijg, J., 1988. Age-dependent accumulation of alkali-labile sites in DNA of post-mitotic but not in that of mitotic rat liver cells. Mech. Ageing Dev. 45, 41-49.
37. Pacifici, R., Davies, K.J.A., 1991. Protein, lipid and DNA repair systems in oxidative stress. Gerontology 37, 165-180.
38. Pawelec, G., Adibzadeh, M., Solana, R., Beckman, I., 1997. The T cell in the aging individual. Mech. Ageing Dev. 93, 35-45.
39. Podlutsky, A. Bastlova, T., Lambert, B., 1996. Reduced proliferation rate of hypoxanthine-phosphoribosyl transferase mutant human T-lymphocytes in vitro. Environ. Mol. Mutagen. 28, 13-18.
40. Schneider, E.L. (Ed.), 1979. The Genetics of Ageing. Plenum Press, New York, p. 27.
41. Singh, N.P., Danner, D.B., Tice, R.R., Pearson, J.D., Brant, L.J., Morrell, C.H., Schneider, E.L., 1991. Basal DNA damage in individual human lymphocytes with age. Mutation Res. 256, 1-6.
42. Smith, M.L., Fornace, A.J., 1996. Mammalian DNA damage-inducible genes associated with growth arrest and apoptosis. Mutation Res. 340, 109-124.
43. Sugimura, T., 1988. Successful use of short-term tests for academic purposes: their use in identification of new environmental carcinogens with possible risk for humans. Mut. Res. 205, 33-39.
44. Takayama, S., Nakatsura, Y., Sato, S., 1987. Carcinogenic effect of the simultaneous administration of five heterocyclic amines to F344 rats. Jpn. J. Cancer Res. 78, 1068-1072.
45. Tates, A.D., Van Dam, F.J., Van Mossel, H. et al., 1991. Use of the clonal assay for the measurement of frequencies of HPRT mutants in T-lymphocytes from five control populations. Mutation Res. 253, 199-213.
46. Trainor, K.J., Wigmore, D.J., Chrysostomou, A., Dempsey, J., Seshadri, R., Morley, A.A., 1984. Mutation frequency in human lymphocytes increases with age. Mech. Age Dev. 27, 83-86.
47. Vijayalaxmi, X., Evans, H.J., 1984. Measurement of spontaneous and X-irradiation induced 6-thioguanine resistant human blood lymphocytes using a T-cell cloning technique. Mutation Res. 125, 87-94.
48. Vogelstein, B., Kinzler, K.W., 1993. The multistep nature of cancer. TIG 9, 138- 141.
49. Wong, G.H.W., Goeddel, D.V., 1988. Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism. Science 242, 941-944.